“…Supplementary Digital Material 3 (Supplementary Table III) 39 - 91 shows the characteristics of the included studies. More than half of the studies (57%, N=30, 2075 participants) included adults with PCC, 42 - 46 , 48 - 51 , 53 , 56 , 57 , 59 - 62 , 64 , 66 , 67 , 70 - 72 , 74 - 76 , 81 , 83 , 85 , 88 , 89 followed by adults with non-severe (34%, N.=18, 1489 participants), severe (6%, N.=3, 230 participants) 39 , 63 , 86 and critical COVID-19 (4%, N.=2, 88 participants). 41 , 90 …”